Metraipolis › archive › dc_7bc2fe7f4dee

Development of Styryl-Modified 3,4-Dihydropyrimidin-2(1H)-ones as Potential Antitumor Agents — Europe PMC PMID:41945791

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41945791
DOI: 10.1002/cmdc.202501073
License (as archived): solo-consultazione
Archived: 2026-11-03T13:00:14.539Z
SHA-256 of the archived text: 0d6fca823fec105661061ec871a13ec4b5bc8eb58e30b1c63f324373e8402a74
Stable URL of this page: https://metraipolis.com/documento/dc_7bc2fe7f4dee

How to cite

Development of Styryl-Modified 3,4-Dihydropyrimidin-2(1H)-ones as Potential Antitumor Agents — Europe PMC PMID:41945791 — Europe PMC (en), https://europepmc.org/article/MED/41945791 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7bc2fe7f4dee (Metraipolis archive dc_7bc2fe7f4dee, sha256 0d6fca823fec105661061ec871a13ec4b5bc8eb58e30b1c63f324373e8402a74)

BibTeX

@misc{dc7bc2fe7f4dee,
  title = {Development of Styryl-Modified 3,4-Dihydropyrimidin-2(1H)-ones as Potential Antitumor Agents — Europe PMC PMID:41945791},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41945791},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7bc2fe7f4dee; sha256 0d6fca823fec105661061ec871a13ec4b5bc8eb58e30b1c63f324373e8402a74},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41945791. Agents can read the archived copy with the MCP tool read_document.